title: Vaccine adjuvants: putting innate immunity to work.
authors.affiliation: Dynavax Technologies Corporation, Berkeley, CA 94710, USA. rcoffman@dynavax.com
authors.forename: Robert L
authors.initials: RL
authors.lastname: Coffman
authors.forename: Alan
authors.initials: A
authors.lastname: Sher
authors.forename: Robert A
authors.initials: RA
authors.lastname: Seder
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000938:Antigen-Presenting Cells / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D007113:Immunity, Innate; D023421:Models, Animal; D020365:RNA Helicases / Q000502:physiology; D051193:Toll-Like Receptors / Q000502:physiology; D014612:Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D051193:Toll-Like Receptors; D014612:Vaccines; D020365:RNA Helicases